Inventor
Mustapha Haddach
Inventor
San Diego, CA, US
Overview
Patents· 30 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds39%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
A61KPreparations for medical, dental or toiletry purposes20%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
10,975,076Compositions, uses and methods for making them202110,745,403Compositions, uses and methods for making them202010,590,134Compositions, uses and methods for making them202010,442,801Compositions, uses and methods for making them20199,951,066Compositions, uses and methods for making them20189,758,518'Compositions, uses and methods for making them'20179,512,123'Compositions, uses and methods for making them'20169,303,033'Pyrazolopyrimidines and related heterocycles as CK2 inhibitors'20168,853,234'Quinolone analogs and methods related thereto'20148,841,295'5-lipoxygenase-activating protein (FLAP) inhibitors'20148,575,177'Pyrazolopyrimidines and related heterocycles as CK2 inhibitors'20138,399,666'5-lipoxygenase-activating protein (FLAP) inhibitors'20138,367,681'Pyrazolopyrimidines and related heterocycles as kinase inhibitors'20138,168,651'Protein kinase modulators'20128,124,649'Oxindole compounds'20127,977,359'5-lipdxygenase-activating protein (FLAP) inhibitors'20117,973,079'Methods and compounds for treating retinol-related diseases'20117,928,100'Quinolone analogs and methods related thereto'20117,910,600'Therapeutic kinase modulators'20116,747,034'CRF receptor antagonists and methods relating thereto'20046,723,721'CRF receptor antagonists and methods relating thereto'20046,610,678'CRF antagonistic quino-and quinazolines'20036,583,143'CRF receptor antagonists and methods relating thereto'20036,541,469'CRF receptor antagonists and methods relating thereto'20036,531,475'CRF receptor antagonists and methods relating thereto'20036,514,982'CRF receptor antagonists and methods relating thereto'20036,500,839'CRF receptor antagonists and methods relating thereto'20026,482,836'CRF antagonistic quino- and quinazolines'20026,440,960'CRF receptor antagonists and methods relating thereto'20026,348,466'CRF receptor antagonists and methods relating thereto'2002Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2002–2004Patents assigned to NEUROCRINE BIOSCIENCES INC (9)· patent assignee history
2002–2021Based in San Diego, CA, US· patent location history
2011–2013Patents assigned to CYLENE PHARMACEUTICALS INC (5)· patent assignee history
2012–2014Patents assigned to HADDACH MUSTAPHA (7)· patent assignee history
2012–2014Patents assigned to PIERRE FABRICE (3)· patent assignee history
2016–2021Patents assigned to PIMERA INC (7)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NEUROCRINE BIOSCIENCES INC | 9 | 2002–2004 |
| HADDACH MUSTAPHAself | 7 | 2012–2014 |
| PIMERA INC | 7 | 2016–2021 |
| CYLENE PHARMACEUTICALS INC | 5 | 2011–2013 |
| PIERRE FABRICE | 3 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 30 | 2002–2021 |